Drugs / Leddermix
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2/3 | NCT06566508 Comparator | Nov 2023 → Jun 2024 overdue | — | Mansoura University | Recruiting | No outcome recorded |
| Phase 2/3 | NCT06466538 Comparator | Jun 2022 → Jul 2024 | — | Mansoura University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Leddermix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06566508 ↗ |
| Route | Other | “intracanal medication” NCT06466538 ↗ |